Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2018/09/11?limit=200®isters=between&mode=atom2024-11-21T14:43:32-08:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19709.htmlNotice - Submission for OMB Review; Comment Request2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19709Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19709.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19674.htmlNotice - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry: Formal Meetings Between the Food and Drug Administration and Biosimilar Biological Product Sponsors or Applicants2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19674Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19674.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19670.htmlNotice - Gastrointestinal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19670Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19670.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19669.htmlNotice - Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19669Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19669.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19668.htmlNotice - Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19668Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19668.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19667.htmlNotice - Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19667Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19667.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19666.htmlNotice - Postapproval Changes to Drug Substances; Draft Guidance for Industry; Availability2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19666Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19666.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19664.htmlNotice - Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Products, User Fees, Requirements for the Submission of Data Needed To Calculate User Fees for Domestic Manufacturers and Importers of Tobacco Products2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19664Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19664.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19663.htmlNotice - Determination That CEFZIL (Cefprozil) Tablets, 250 Milligrams and 500 Milligrams, and for Oral Suspension, 125 Milligrams/5 Milliliters and 250 Milligrams/5 Milliliters, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19663Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19663.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19609.htmlNotice - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19609Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19609.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19608.htmlNotice - National Institute on Drug Abuse Amended; Notice of Meeting2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19608Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19608.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19607.htmlNotice - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19607Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19607.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19606.htmlNotice - National Eye Institute; Notice of Meeting2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19606Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19606.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19605.htmlNotice - Center for Scientific Review; Notice of Closed Meetings2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19605Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19605.pdfhttps://regulations.justia.com/regulations/fedreg/2018/09/11/2018-19604.htmlNotice - Prospective Grant of an Exclusive Patent License: Photoactivatable Liposomal Nanoparticle for the Delivery of an Immunotherapeutic or Immunotherapeutic-Enabling Agent2018-09-11T00:00:00-07:002018-09-11T00:00:00-07:002018-19604Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19604.pdf